US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by AscellaHealth, LLC
AscellaHealth Advances AscellaOne Technology Strategy, Names Asad Shoostry Chief Technology Officer
September 15, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Delivers Mid-Year Specialty Pharmacy Outlook to Help Payers Navigate Pipeline Innovation, Cost and Benefit Strategy
July 30, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Appoints Industry Veteran Johanna van Nijkerk as Vice President of Business Development to Advance National Accounts and Drive Growth of AscellaOne
July 28, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management
July 14, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
Announcing the 2026 Hall of Fame Philadelphia Titan 100 Honorees
June 11, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity
June 09, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Inaugurates Strategic Advisory Council, With Founding Members, Advances Pharmacy Benefits Ecosystem Through Technology Deployment and Specialty Expertise
April 14, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Named to Financial Times Americas’ Fastest Growing Companies 2026 List
April 07, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Expands International Operations, Broadens Executive Leadership to Accelerate Global Market Access for Life Sciences
February 11, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Launches Strategic Pharmacy Benefits Enablement Platform to Address 2026 Healthcare Cost and Access Challenges
January 14, 2026
From
AscellaHealth, LLC
Via
GlobeNewswire
CHAPPER healthcare, AscellaHealth’s Global Pharmaceutical Distributor, Celebrates 50 Years of Global Pharmaceutical Excellence
October 13, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)
October 09, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Leaders Take the Stage at SIIA National Conference: Present Strategies for Managing High-Cost Claims and Building Pharma Partnerships
October 07, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
August 12, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients
July 29, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
Tickers
ABEO
AscellaHealth Service and Infrastructure Enhancements Support Specialty Drug Manufacturers to Protect Market Share Across Brand, Biosimilar and Generic Launches
July 23, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies
July 15, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Launches Q2 2025 Specialty & Rare Pipeline Digest™ to Support Stakeholders Navigating Specialty Drug Growth
July 10, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
Optime Care Partners with Tilde Sciences as Exclusive Specialty Pharmacy Provider for Vecamyl
June 23, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Wins Business Change and Transformation Excellence Award at the Industry Eagles Awards 2025
June 17, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
Announcing the 2025 Philadelphia Titan 100 Recipients
June 10, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth to Present on Site of Care Strategies for High-Cost Medications at SIIA Stakeholder Forum
May 20, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!
May 13, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
April 29, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
Actum Pharma Expands Executive Team to Launch Enhanced Services Program to Support Biopharma Product Commercialization and Market Success
April 17, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Demonstrates Leadership in Realizing the Full Potential of Novel Therapies and Medicinal Products at Advanced Therapies Integrates North 2025
April 22, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit
April 15, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Showcases Rare Disease Expertise and Comprehensive Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025
April 08, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates
April 02, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®
March 04, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
